The effect of glucocorticoid on cell proliferation,
Materials and Methods
(provided by the Japanese Cancer Research Resources Bank, Tokyo), the human astrocytoma cell line KNS4216) (gift of Dr. I. Takeshita, Kyushu University, Fukuoka), and the human astrocytoma cell line U251MG2) (provided by the Japanese Cancer Research Resources Bank) were cultured in 100 mm dishes with RPMI1640 medium containing 10% fetal bovine serum, kanamycin monosulfate (100 mg/1), and L-glutamine (2932.3 mg/1). Cells were main tained at 37° C in a humidified atmosphere of 5% CO2 and 95% air.
Dexamethasone was stored in ethanol at -800C and diluted in culture medium just before use. RU38486 (generous gift from Roussel Uclaf Pharma ceuticals, Romainville, France)5) was also stored in ethanol at 80° C and diluted in culture medium be fore use (10-5 M) to prevent dexamethasone binding to glucocorticoid receptors.
Only ethanol was added to the control culture medium. The final concentra tion of ethanol was 0.1%.
I.
Cell culture The human glioblastoma cell lines T98G,15) A17271 II. Effect of dexamethasone on cell growth 1.0 x 104 cells/ml were dispensed into wells of 96 well plates in 100 ml of RPMI1640 medium. After 2 3 days of culture, the medium was replaced with medium containing different concentrations of dex amethasone (10-4 M, 10-5 M, 10-6 M, or 10-7 M) and cultured for 3-5 days. 3-(4,5-Dimethylthiazol-2 yl)-2,5-diphenyl tetrazolium bromide (MTT) stock so lution was prepared at a concentration of 5 mg/ml phosphate buffered saline (PBS). 10 ml of MTT stock solution was added to each well and then wells were further incubated at 37° C for 6 hours. Subsequently, 150 ml isopropanol containing 0.04N HC1 was added and the absorbance of each well was meas ured using an enzyme immunoreader (which auto matically subtracts non-specific background from available data) at 495 nm. Cells growth was ex pressed as a percentage of mean control absorbance ± SEM, following subtraction of the mean absor bance of background.
Examinations were per formed three times for each sample.
III.
Expression of glucocorticoid receptor
Cell pellets obtained from cultured cells were washed twice with PBS, pH 7.4 for 5 minutes and lysed with 200 ml of phenylmethylsulfonyl fluoride buffer consisting of 1% NP 40, 0.1% sodium deox ycholate, 150 mM NaCI, 50 mM Tris-HC1 (pH 7.5), 1 mM phenylmethane sulfonyl fluoride, and 0.2 U/ml aprotinin. Cell pellets were homogenized with a microwave homogenizer at 4'C for 2 minutes and the lysates were centrifuged at 15,000 rpm at 4° C for 20 minutes. Supernatants were collected, mixed with 100 ml of sodium dodecyl sulfate sample buffer, incubated at 100'C for 5 minutes, and rap idly cooled on ice. Cell lysates were subjected to denaturing electrophoresis on 10% polyacrylamide gels and then transferred to nitrocellulose mem branes. Membranes were processed for Western blot analysis using a 1:200 dilution of primary antibody (polyclonal rabbit anti-human glucocorticoid recep tor antibody; Affinity BioReagents, Inc., Golden, Colo., U.S.A.)3) followed by incubation with biotinylated goat anti-rabbit immunoglobulin G (IgG) at a dilution of 1:1000 for 30 minutes, with streptoavidin-biotin-peroxidase complex (1:1000) for 30 minutes. Signals were detected by the Amersham ECL system (Amersham Japan, Tokyo). for 10 minutes and fixed in 4% paraformaldehyde, pH 7.2 for 10 minutes at 4'C. After fixation, cover glasses were washed twice with PBS for 5 minutes and permeabilized in 0.3% Triton X-100 for 20 minutes. After PBS wash, cells were incubated in 3% normal goat serum in PBS for 20 minutes to reduce nonspecific background staining. Cover glasses were incubated overnight at 40C with an anti-glucocorticoid receptor antibody (polyclonal rabbit anti-human glucocorticoid receptor antibody; Affinity BioReagents, Inc.)3) at a concentration of 5 mg/ml, then in biotinylated goat anti-rabbit IgG at a dilution of 1:400 for 1 hour, in avidin-biotin complex (1:200) for 30 minutes, and in a diaminobenzidine hydrogen peroxide solution for 15 minutes.
V.
Effect of dexamethasone on cell apoptosis 1 x 105 cells were collected from 100-mm dishes, centrifuged, and washed twice with PBS at 3-5 days after treatment with dexamethasone with and without RU38486. The cell pellets were lysed in 100 ml of buffer consisting of 10 mM Tris-HCI buffer, 10 mM ethylenediaminetetra-acetic acid (EDTA) (pH 8.0), and 0.5% Triton X-100. After 4 minutes rota tion at 4° C, the cell lysates were centrifuged at 16,000 rpm for 20 minutes at room temperature. The supernatant containing ribonucleic acid (RNA) and fragmented deoxyribonucleic acid (DNA) was col lected in a 1.5 ml tube and incubated at 37° C for 60 minutes with 5 ml ribonuclease A (10 mg/ml) to digest RNA. Five ml of proteinase K (10 mg/ml) was added and incubated at 37° C for 60 minutes, and the DNA was precipitated by 20 ml 5 M NaCl and 120 ml isopropanol at 20° C overnight. The lysates were centrifuged at 16,000 rpm for 20 minutes and the pellets were collected, air dried, and dissolved in 20 ml of Tris-EDTA buffer. Samples were elec trophoresed on a 2% agarose gel with Tris-acetate, EDTA buffer. Fragmented DNA was visualized with ethidium bromide staining. This method was modi fied to exclude high molecular weight DNA when ex tracting fragmented DNA.
Results

I.
Effect of dexamethasone on cell growth
The effect of dexamethasone on cell growth was in vestigated as the relationship between the concentra tion of dexamethasone and the absorbance of cells measured in the MTT assay (Fig. 1) Western blot analysis of the neuroepithelial tumor cell lines (KNS42, T98G, A172, and U251MG) showed glucocorticoid receptor protein bands of ap proximately 97 kDa in T98G, A172, and KNS42 cells, but not in U251MG cells (Fig. 3) . Immunocytochemical analysis showed that KNS42, T98G, and A172 cells had clear positive glucocorticoid receptor staining in the cytoplasm. There was strong nuclear staining in dexametha sone-treated cells (Fig. 4) , in contrast to weak In contrast, cytoplasmic staining and weak nuclear staining is ob served in KNS42 (A), T98G (C), and A172 (E) untreated cells. Original magnification x 200. In con trast, dose-dependent increase of KNS42 and T98G cell growth was found at dexamethasone concentra tions of 10-7 M to 10-5 M, but cell numbers sharply decreased at the concentration of 10-4 M, and some cultured cells were visible at the surface of medium in dishes. Therefore, this process was not due to apoptosis induced by dexamethasone or over proliferation. Leukemia cells undergo glucocorti coid-induced apoptosis dose-dependently from 10-9 M to 10-4 M, but a concentration of 10-4 M dex amethasone is 103 times that of physiological range and is likely to damage cultured cells. We conclude that the inhibition obtained after high dose treat ment of KNS42 and T98G cells was probably not due to receptor mediation, but necrotic changes, result ing from cell membrane changes.14) A substantial dose of dexamethasone would be necessary to achieve an anti-tumor effect against KNS42 and T98G cells. These results suggest that the glucocorti coid-receptor complex acts differently in the regula tion of gene expression and molecular synthesis related to cell proliferation in individual cell lines. The complex might turn on acceleration of cell growth-related gene in KNS42 and T98G cells, but suppress of cell growth-related gene in A172 cells.
High-dose treatment has achieved an anti-neoplas tic effect in a patient with a glioma expressing glucocorticoid receptor,',') and a bimodal response to glucocorticoid in primary cultured astrocytic cells obtained during surgery") and established astro cytic tumor cell lines, HU197, D384, or WF,13,1'1 which all express glucocorticoid receptor. The bi modal potential to stimulate or suppress prolifera tion of neuroepithelial tumor cells expressing glucocorticoid receptor must be considered in clini cal trials of glucocorticoid by selecting the appropri ate concentration (from 10-8 M to 10-7 M). Further research is necessary to analyze the mechanism of the gene site that mediates the regulation of cell growth by glucocorticoid-receptor complex in in dividual cell lines to explain the heterogeneous response in vitro and to examine whether dex amethasone can regulate tumor cell proliferation in vivo. 
Commentary
The authors reported the effects of dexamethasone on the cell proliferation of neuroepithelial tumor lines ex pressing glucocorticoid receptors. Interestingly, the ef fects o f dexamethasone on the proliferation o f tumor cells depended on its concentration in the culture su pernatants. Cell proliferation was enhanced at low concentration of dexamethasone whereas it was in hibited at high concentration. They suggested that this bimodal effect of dexamethasone might be at tributed to an inhibitor of glucocorticoid receptor com plex in the cytoplasm or nucleus. We previously reported that suramin, a non specific antagonist for growth factors, showed bimodal actions on the proliferation o f human glioma cells. Similarly to dex amethasone, suramin promoted the proliferation o f cells at low concentration and inhibited it at high con centration. We further investigated the mechanism of intracellular signaling caused by suramin. In the cells treated with a low concentration of suramin, activity of MAP kinase was higher than those treated with high concentration. MAP kinase is one of the regula tors o f cell growth. I agree with the authors on the point that dexamethasone may cause unwanted ef fects on cell growth during administration or when the plasma level of dexamethasone decreases after one-course treatment, and that glioma cells which responded to dexamethasone by such mechanism may grow unexpectedly.
